EUVIMEDEUVIMED entdecken
Crossref

A UHPLC-Q/TOF-MS/MS-based systematic strategy for analysis of chemical constituents and rat metabolite profiles of modified Shengmai powder

Meng Zhou, Huizhi Luo, Jingjing Ding, Qi Lv, Wanyue She, Jueying Wang, Xiquan Xu, Maidina Aimurula, Changyin Li, Rong Sun, Liyuan Tian, Yu Gu

Journal of Pharmaceutical and Biomedical Analysis · 2026

DOI: 10.1016/j.jpba.2025.117150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Meng Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing University of Chinese Medicine, No.282, Hanzhong Road, Nanjing, Jiangsu Province 210029, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Drugs, Chinese Herbal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Nanjing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modified Shengmai Powder (MSP), derived from a classical formula in Yixue Qiyuan, has demonstrated clinical efficacy in alleviating radiation-induced injuries. However, its holistic chemical constituents and in vivo bioactive constituents remain unclear. In this study, a systematic strategy based on ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (UHPLC-Q/TOF-MS/MS) combined with the MS-DIAL and MS-FLO platforms was developed to analyze the chemical constituents of MSP and its metabolite profiles in rats. As a result, a total of 121 chemical constituents in MSP were identified, including 33 phenylpropanoids, 21 terpenes, 18 flavonoids, 14 saponins, 11 organic acids, 10 glycosides, 5 amino acids, 2 sugars, and 7 others. Chlorogenic acid was identified as the predominant constituent and was recommended as a key quality marker. Furthermore, 38 prototype constituents and 47 metabolites were identified in serum, urine, and feces of rats. It was also observed that metabolic pathways primarily involved phase I processes, mainly including oxidation, reduction, and hydrolysis, while phase II pathways and their associated metabolites were relatively less prominent. In conclusion, this study identified the chemical constituents of MSP and characterized their metabolite profiles in rat serum, urine and feces. These findings provide a scientific basis for further exploration of the material basis underlying MSP efficacy and offer theoretical support for understanding its mechanism of action and clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryDrugs, Chinese HerbalAnimalsChromatography, High Pressure LiquidRatsMaleRats, Sprague-DawleyDrug CombinationsPowdersFeces

Stichwörter der Autor:innen

Chemical constituentsMetabolite profilesModified Shengmai PowderUHPLC-Q/TOF-MS/MS

Substanzen

Drugs, Chinese Herbalfructus schizandrae, radix ginseng, radix ophiopogonis drug combinationDrug CombinationsPowders

Autor:innen und Institutionen

  • Nanjing University of Chinese Medicine, No.282, Hanzhong Road, Nanjing, Jiangsu Province 210029, China.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, No.155, Hanzhong Road, Nanjing 210029, China. Electronic address: fsyy00612@njucm.edu.cn.
  • Department of Radiation Oncology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, China. Electronic address: doctorsunrong818@163.com.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, No.155, Hanzhong Road, Nanjing 210029, China. Electronic address: tianliyuan2023@163.com.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, No.155, Hanzhong Road, Nanjing 210029, China. Electronic address: guyugg@njucm.edu.cn.

Förderung

  • Nanjing University of Chinese Medicine

Zitieren

APA

Zhou, M., Luo, H., Ding, J., Lv, Q., She, W., Wang, J., Xu, X., Aimurula, M., Li, C., Sun, R., Tian, L., & Gu, Y. (2026). A UHPLC-Q/TOF-MS/MS-based systematic strategy for analysis of chemical constituents and rat metabolite profiles of modified Shengmai powder. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.117150

Vancouver

Zhou M, Luo H, Ding J, Lv Q, She W, Wang J, et al. A UHPLC-Q/TOF-MS/MS-based systematic strategy for analysis of chemical constituents and rat metabolite profiles of modified Shengmai powder. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2025.117150

BibTeX
@article{Zhou2026,
  author = {Zhou, Meng and Luo, Huizhi and Ding, Jingjing and Lv, Qi and She, Wanyue and Wang, Jueying and Xu, Xiquan and Aimurula, Maidina and Li, Changyin and Sun, Rong and Tian, Liyuan and Gu, Yu},
  title = {A UHPLC-Q/TOF-MS/MS-based systematic strategy for analysis of chemical constituents and rat metabolite profiles of modified Shengmai powder},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  doi = {10.1016/j.jpba.2025.117150}
}
Kostenlos starten →